Gastroenterology News and Research

RSS

Gastroenterology is the branch of medicine where the digestive system and its disorders are studied.

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.

14 Aug 2018

AI platform identifies acute neurological illnesses faster than human diagnosis

An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than human diagnosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the journal Nature Medicine.

14 Aug 2018

NIH awards $6.5 million to establish multi-institution biomedical technology resource center

The National Institutes of Health have awarded $6.5 million to a consortium that includes the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai, the University of Washington, the University of Connecticut, and the University of Auckland, New Zealand, to establish the Center for Reproducible Biomedical Modeling.

13 Aug 2018

Scientists find genetic marker that indicates a person's risk for tachycardia-induced cardiomyopathy

Scientists in Japan have found a potential marker to identify which people with abnormally fast heartbeats are at high risk of developing heart failure.

9 Aug 2018

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in JCO Precision Oncology in August.

9 Aug 2018

Study suggests link between probiotic use and “brain fogginess”

A study conducted at the Medical College of Georgia at Augusta University has shown that probiotic intake can result in a significant build-up of small intestine bacteria that leads to brain fogginess.

8 Aug 2018

Taking cholesterol-busting pills can effectively treat brutal PAP

Researchers report in Nature Communications they figured out why air sacs in the lungs clog up with a thick substance called surfactant in a brutal disease called Pulmonary Alveolar Proteinosis, and they show taking cholesterol-busting pills called statins can effectively treat the disease.

7 Aug 2018

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use can result in a significant accumulation of bacteria in the small intestine that can result in disorienting brain fogginess as well as rapid, significant belly bloating, investigators report.

6 Aug 2018

New drug cocktails make targeted cancer therapies more efficient with less side effects

Mount Sinai researchers have discovered that certain drug cocktails help targeted therapies attack cancer more efficiently while lessening common side effects, according to a study published today in Cancer Research.

1 Aug 2018

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers - those born between 1945-1965 - are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

27 Jul 2018

CellMax Life receives six U.S. patents for early cancer detection blood test

CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.

26 Jul 2018

The Mount Sinai Hospital receives accreditation as geriatric emergency department

The Department of Emergency Medicine at The Mount Sinai Hospital is the first in New York State to be accredited as a geriatric emergency department by the American College of Emergency Physicians. Eight emergency departments in the nation received this accreditation, which is part of a nationwide effort to improve and standardize emergency care for elderly patients.

20 Jul 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

Alcohol-related cirrhosis mortality on the rise among young adults

Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

19 Jul 2018

Key innovations awards recognize PENTAX Medical for new product developments

PENTAX Medical is pleased to announce that the innovation within its new product developments has been recognized by two key awards.

From PENTAX Medical Company 6 Jul 2018

Researchers develop ingestible sensor to non-invasively monitor indicators of disease

NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.

6 Jul 2018

Mount Sinai study identifies potential new treatment target for aggressive bladder cancer

A potential new target for treatment has been identified in an aggressive form of bladder cancer, Mount Sinai researchers report.

4 Jul 2018

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.

2 Jul 2018

Simple DNA test can predict risk of bad side effects to thiopurine drugs

Screening a tiny section of DNA could help East Asian patients avoid severe reactions to some medications.

2 Jul 2018

Gastroenterology News and Research

Further Reading

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

AI platform identifies acute neurological illnesses faster than human diagnosis

NIH awards $6.5 million to establish multi-institution biomedical technology resource center

Scientists find genetic marker that indicates a person's risk for tachycardia-induced cardiomyopathy

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Study suggests link between probiotic use and “brain fogginess”

Taking cholesterol-busting pills can effectively treat brutal PAP

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

New drug cocktails make targeted cancer therapies more efficient with less side effects

Researchers emphasize need for baby boomers to get tested for hepatitis C

CellMax Life receives six U.S. patents for early cancer detection blood test

The Mount Sinai Hospital receives accreditation as geriatric emergency department

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Alcohol-related cirrhosis mortality on the rise among young adults

Key innovations awards recognize PENTAX Medical for new product developments

Researchers develop ingestible sensor to non-invasively monitor indicators of disease

Mount Sinai study identifies potential new treatment target for aggressive bladder cancer

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Simple DNA test can predict risk of bad side effects to thiopurine drugs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News